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When the high-level Taskforce on Innova-
tive International Financing for Health 
Systems was launched in September 2008, 
with a 12-month timetable, it faced a vast 
array of challenges. A global financial crisis 
was gaining momentum, leading many to 
think that there was no chance of getting 
political support for raising additional 
funds for the United Nations Millen-
nium Development Goals (MDGs) for 
low-income countries. Other challenges 
included differing views on how to define 
and handle international investments in 
“health systems”, concerns by some donors 
on the value for money of much official 
development assistance, and a growing 
number of competing priorities such as the 
food crisis and climate change.
However, by the end of the 12-month 
period, a large number of world leaders 
met in New York to announce expanding 
support to several initiatives valued at more 
than 5 billion United States dollars (US$) 
in low-income countries, with a particular 
focus on maternal and child health services. 
These announcements came at the end of 
a year of detailed analyses by some lead-
ing figures in international health and a 
series of lively consultations and debates 
that have brought much needed energy to 
previously ignored areas. This paper sum-
marizes how the taskforce was conducted, 
its key achievements and progress made 
since the work was completed. A detailed 
description of the challenges the workforce 
faced has already been published.1
The taskforce
The taskforce was an innovation itself in 
the way it was set up and run. Prime Min-
isters Gordon Brown (United Kingdom 
of Great Britain and Northern Ireland) 
and Jens Stoltenberg (Norway) were the 
original driving force, using their offices to 
bring in The World Bank president, Robert 
Zoellick, as co-chair and the Director-
General of the World Health Organization 
(WHO), Margaret Chan. Japan and the 
Netherlands joined later in 2009, drawn in 
by the process of consensus building. Final 
membership consisted of three heads of 
state (Liberia, Norway, United Kingdom), 
two heads of international institutions 
(The World Bank and WHO), six minis-
ters (Australia, Ethiopia, France, Germany, 
Italy and the Netherlands), two special 
advisers (for Japan and the United Nations 
Secretary-General) and a representative of 
civil society (Graça Machel). The taskforce 
met four times: at the Conference on Fi-
nancing for Development in Doha in De-
cember 2008, in Downing Street, London, 
before the G20 Summit in March 2009, in 
Paris during the French-led Leading Group 
on Innovative Financing for Development 
conference in May 2009, and in New York 
during the United Nations General As-
sembly in September 2009. Its secretariat 
was provided by the International Health 
Partnership Plus (IHP+) and the United 
Kingdom’s Department for International 
Development.
Key achievements
Articulation of needs
When the taskforce started its work, 
different groups expressed the main con-
straints to scaling up health services in 
disparate ways. In many areas, important 
ideas were not being clearly articulated to 
national and international policy-makers. 
Through a large, widely representative 
working group, the final report from 
taskforce working group 1 successfully 
expressed the main constraints and policy 
responses to scaling up health services in 
low-income countries.2
Unified costing
At the start of the taskforce’s work, differ-
ent international groups were promoting a 
plethora of costing tools and approaches 
to developing countries. The taskforce 
chose to publish two cost analyses based 
on quite different assumptions – one 
focusing on high levels of early capital 
investment and the other on more gradual 
increases in capital.1,2 The effort promoted 
close collaboration and allowed more 
detailed discussion on standards for fu-
ture work. This will hopefully reduce the 
current confusion in countries and allow 
more efficient support by the United 
Nations and The World Bank. Given the 
limited time available, the intention was 
to produce plausible aggregate numbers 
rather than numbers that were robust 
at the country level. The country data 
used to produce the aggregates has not 
been made public. However the aim is to 
continue to develop country plans and 
related costs, as has already started under 
the IHP+ and related initiatives.
Improved domestic finance
Although not in the terms of reference of 
the taskforce, the analysis clearly showed 
the fundamental importance of improving 
domestic health financing policy to meet 
the health MDGs in an equitable way. These 
conclusions were quickly highlighted by 
those advocating for more funds for health 
in developing countries. A landmark con-
sultation between taskforce members and 
African parliamentarians in Addis Ababa, 
Ethiopia, focused on the potentially greater 
impact that a relatively small amount of 
international funds could have if used in 
conjunction with domestic finances. The 
final recommendations of the taskforce echo 
the sentiments of that meeting.3
Innovative finance
The taskforce decided to recommend only 
those innovative financing mechanisms 
that had a clear sponsor for implementa-
tion. However, the analysis in the working 
group 2 report and the submissions made 
to the taskforce provide a rich array of 
ideas for countries to consider, both for 
health and other social sectors.4 Some 
mechanisms clearly required further work 
before they could be put into action. The 
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inclusion of the currency transaction 
levy in one of the recommendations, 
for example, was a key step in helping to 
promote it to a wider set of stakeholders, 
led by civil society activists and the Gov-
ernment of France.
Making better use of funds
The taskforce recommended expansion 
of support to the IHP+, which aims to 
better link international financial aid 
to results in countries. Central to these 
efforts are more robust country-level 
planning, costing, budgeting and moni-
toring. IHP+ was closely involved in the 
work of the taskforce and its momentum 
continues to grow. In addition, the United 
States of America is also aligning its sup-
port more closely with national policies 
and plans of developing countries with 
proactive governments.
Health systems strengthening 
platform
One of the key outcomes of the taskforce 
was the recommendation of a more ef-
ficient approach to health investments 
by the three main multilateral health 
sector donors – The World Bank, the 
Global Fund to Fight AIDS, Tuberculo-
sis and Malaria and the GAVI Alliance. 
Some countries are now piloting a closer 
collaboration across agencies on result-
driven investments within their national 
health plans and strategies. But it is an 
area where there is still a lot to be learnt. 
However, this could be key to unblocking 
many constraints to expanding health 
services and improving efficiency of the 
international health architecture.
Monitoring commitments
Another key success of the taskforce was 
the agreement to a regular Health and 
Development Forum where global and 
country commitments can be more openly 
monitored. This started under the IHP+, 
but will now be a broader group of coun-
tries given that the previous IHP+ ministe-
rial meeting was criticized for missing out 
many of the poorer countries which have 
not had as much international support.
Challenges
A paper recently published1 outlines 
the many problems the taskforce faced, 
including the short timeframe for com-
pleting technical work and mobilizing 
political support for the recommenda-
tions, limitations in the evidence base 
and areas of disagreement – particularly 
over the role of non-state actors and pub-
lic–private partnerships. On the other 
hand, the tight timeline may have actu-
ally contributed to its success, reducing 
opportunities for confusion and delays. 
An extended reporting period may have 
encountered more problems due to politi-
cal changes in donor countries.
Concerns have been expressed that 
the “innovative finance” proposals may 
detract public and government support in 
some donor countries for the United Na-
tions target of 0.7% of gross national in-
come for official development assistance. 
However, some members of the taskforce 
argued forcefully that more innovative 
mechanisms could lead to greater public 
engagement and support. Examples in-
clude the International Finance Facility 
for Immunisation (IFFIm) bonds, and 
joint government and business initiatives 
such as the “D-Tax” (announced by Italy), 
which aim to encourage the general public 
to support and be engaged in interna-
tional health aid in low-income settings.4
Progress
Progress on many of the final announce-
ments is already well underway in 2010. 
This includes US$ 1 billion to expand 
health system investments through IF-
FIm and US$ 400 million to expand the 
Health Results Innovation Trust Fund 
held by The World Bank. Some of the 
announcements reaffirm support for on-
going work, such as for Advance Market 
Commitments for vaccines and the Debt-
2Health initiative by the Global Fund. 
Some areas were completely new and have 
yet to prove they can deliver, such as the 
D-Tax and the “Massive Good” initiative 
managed by the Millennium Foundation 
for Innovative Finance for Health. An 
independent assessment of this initia-
tive by The World Bank suggested that 
US$ 3.2 billion could be raised before 
2015 through a coordinated effort within 
the travel industry. As with the airline 
tax used to fund UNITAID, those who 
initially scoffed at these innovations may 
well be proven wrong.
Conclusion
The taskforce delivered on its terms of 
reference and produced recommenda-
tions, despite the dire global financial 
circumstances. Perhaps its most impor-
tant outcome was driving the momentum 
for health aid in developing countries 
– not an easy task given that donors and 
ministers of finance have many other 
competing interests. Political engagement 
at the highest level was critical to this. The 
consultations with civil society, particular 
those hosted by Graça Machel in Africa, 
and with African parliamentarians in 
the Economic Commission for Africa 
in Addis Ababa, showed the growing 
importance of engaging with regional 
and national lobbies in low-income set-
tings. Of course, not all will be content 
with the taskforce findings and many will, 
no doubt, be concerned that they were 
not adequately consulted. However, the 
taskforce has started on the right track 
by linking international, regional and 
national efforts to mobilize resources 
for health in the poorest countries more 
effectively, in a way that aims at giving 
value for money. ■
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